These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2258903)

  • 1. Synthesis and biochemical evaluation of tritium-labeled 1-methyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxa mide, a useful radioligand for 5HT3 receptors.
    Robertson DW; Bloomquist W; Cohen ML; Reid LR; Schenck K; Wong DT
    J Med Chem; 1990 Dec; 33(12):3176-81. PubMed ID: 2258903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific [3H]LY278584 binding to 5-HT3 recognition sites in rat cerebral cortex.
    Wong DT; Robertson DW; Reid LR
    Eur J Pharmacol; 1989 Jul; 166(1):107-10. PubMed ID: 2806363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane-bound and solubilized brain 5HT3 receptors: improved radioligand binding assays using bovine area postrema or rat cortex and the radioligands 3H-GR65630, 3H-BRL43694, and 3H-LY278584.
    Miller K; Weisberg E; Fletcher PW; Teitler M
    Synapse; 1992 May; 11(1):58-66. PubMed ID: 1318585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
    Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
    Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships.
    Robertson DW; Lacefield WB; Bloomquist W; Pfeifer W; Simon RL; Cohen ML
    J Med Chem; 1992 Jan; 35(2):310-9. PubMed ID: 1732548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indazoles as indole bioisosteres: synthesis and evaluation of the tropanyl ester and amide of indazole-3-carboxylate as antagonists at the serotonin 5HT3 receptor.
    Fludzinski P; Evrard DA; Bloomquist WE; Lacefield WB; Pfeifer W; Jones ND; Deeter JB; Cohen ML
    J Med Chem; 1987 Sep; 30(9):1535-7. PubMed ID: 3625701
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonistic activities of N-3389, a newly synthesized diazabicyclo derivative, at 5-HT3 and 5-HT4 receptors.
    Hagihara K; Hayakawa T; Arai T; Eguchi H; Mino S; Kawase S
    Eur J Pharmacol; 1994 Dec; 271(1):159-66. PubMed ID: 7698198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of 5-hydroxytryptamine3 receptors in murine brain and ileum using the novel radioligand [3H]RS-42358-197: evidence for receptor heterogeneity.
    Bonhaus DW; Wong EH; Stefanich E; Kunysz EA; Eglen RM
    J Neurochem; 1993 Nov; 61(5):1927-32. PubMed ID: 8229003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of [125I]-(S)-iodozacopride, a high affinity radioligand for 5HT3 receptors.
    Gehlert DR; Schober DA; Gackenheimer SL; Mais DE; Ladouceur G; Robertson DW
    Neurochem Int; 1993 Oct; 23(4):373-83. PubMed ID: 8220179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of [3H]YM060, a potent and selective 5-HT3 receptor radioligand, in the cerebral cortex of rats.
    Akuzawa S; Miyata K; Fukutomi H
    Eur J Pharmacol; 1995 Jul; 281(1):37-42. PubMed ID: 8566114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of a tritium-labeled indolidan analogue and its use as a radioligand for phosphodiesterase-inhibitor cardiotonic binding sites.
    Robertson DW; Krushinski JH; Utterback BG; Kauffman RF
    J Med Chem; 1989 Jul; 32(7):1476-80. PubMed ID: 2738882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological and regional characterization of [3H]LY278584 binding sites in human brain.
    Abi-Dargham A; Laruelle M; Wong DT; Robertson DW; Weinberger DR; Kleinman JE
    J Neurochem; 1993 Feb; 60(2):730-7. PubMed ID: 8419547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
    Hemedah M; Coupar IM; Mitchelson FJ
    Br J Pharmacol; 1999 Jan; 126(1):179-88. PubMed ID: 10051134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity of mosapride citrate, a new gastroprokinetic agent, for 5-HT4 receptors in guinea pig ileum.
    Yoshikawa T; Yoshida N; Mine Y; Hosoki K
    Jpn J Pharmacol; 1998 May; 77(1):53-9. PubMed ID: 9639060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels sigma-1 but not sigma-2 binding sites in guinea pig brain.
    Bonhaus DW; Loury DN; Jakeman LB; Hsu SA; To ZP; Leung E; Zeitung KD; Eglen RM; Wong EH
    J Pharmacol Exp Ther; 1994 Oct; 271(1):484-93. PubMed ID: 7965749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
    Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML
    J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-hydroxytryptamine6 receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum.
    Boess FG; Riemer C; Bös M; Bentley J; Bourson A; Sleight AJ
    Mol Pharmacol; 1998 Sep; 54(3):577-83. PubMed ID: 9730917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
    Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
    Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and distribution of 5-HT3 recognition sites in the rat gastrointestinal tract.
    Champaneria S; Costall B; Naylor RJ; Robertson DW
    Br J Pharmacol; 1992 Jul; 106(3):693-6. PubMed ID: 1504752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
    Leonhardt S; Gorospe E; Hoffman BJ; Teitler M
    Mol Pharmacol; 1992 Aug; 42(2):328-35. PubMed ID: 1355262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.